Skip to menu Skip to content Skip to footer

2007

Journal Article

Automated laboratory reporting of estimated glomerular filtration rate: is it good for the health of patients and their doctors?

Noble, Euan and Johnson, David W. (2007). Automated laboratory reporting of estimated glomerular filtration rate: is it good for the health of patients and their doctors?. Biochemia Medica, 17 (1), 16-28.

Automated laboratory reporting of estimated glomerular filtration rate: is it good for the health of patients and their doctors?

2007

Journal Article

Is it time to revisit residual renal function in haemodialysis?

Ng, Tsun G., Johnson, David W. and Hawley, Carmel M. (2007). Is it time to revisit residual renal function in haemodialysis?. Nephrology, 12 (3), 209-217. doi: 10.1111/j.1440-1797.2007.00795.x

Is it time to revisit residual renal function in haemodialysis?

2007

Journal Article

Baseline and time-averaged fluid removal affect technique survival in peritoneal dialysis in a non-linear fashion

Wiggins, Kathryn J., Rumpsfeld, Markus, Hawley, Carmel M., O'Shea, Amanda, Isbel, Nicole M., Campbell, Scott B. and Johnson, David W. (2007). Baseline and time-averaged fluid removal affect technique survival in peritoneal dialysis in a non-linear fashion. Nephrology, 12 (3), 218-223. doi: 10.1111/j.1440-1797.2006.00702.x

Baseline and time-averaged fluid removal affect technique survival in peritoneal dialysis in a non-linear fashion

2007

Journal Article

Check program on chronic kidney disease

Johnson, D. W., Hawley, C. M. and Mathew, T. (2007). Check program on chronic kidney disease. Check, Unit 423

Check program on chronic kidney disease

2007

Journal Article

Early to moderate chronic kidney disease

Mathew, Tim and Johnson, David (2007). Early to moderate chronic kidney disease. Medical Observer.

Early to moderate chronic kidney disease

2007

Journal Article

Distal tubular epithelial cells of the kidney: Potential support for proximal tubular cell survival after renal injury

Gobe, Glenda C. and Johnson, David W. (2007). Distal tubular epithelial cells of the kidney: Potential support for proximal tubular cell survival after renal injury. The International Journal of Biochemistry & Cell Biology, 39 (9), 1551-1561. doi: 10.1016/j.biocel.2007.04.025

Distal tubular epithelial cells of the kidney: Potential support for proximal tubular cell survival after renal injury

2007

Journal Article

Prevention of progression of kidney disease: CARI guidelines

Johnson, David W. (2007). Prevention of progression of kidney disease: CARI guidelines. Australian Family Physician, 36 (5), 353-353.

Prevention of progression of kidney disease: CARI guidelines

2007

Journal Article

How to treat: Resistant hypertension

Johnson, David W. (2007). How to treat: Resistant hypertension. Australian Doctor, 20, 27-28, 30-32, 34.

How to treat: Resistant hypertension

2007

Journal Article

Resistant hypertension

Johnson D.W. (2007). Resistant hypertension. Australian Doctor (20/APR)

Resistant hypertension

2007

Journal Article

Drug dosing adjustment in people with reduced GFR

Mathew, Timothy, Jones, Graham and Johnson, David (2007). Drug dosing adjustment in people with reduced GFR. Australian Prescriber, 30 (2), 34-34.

Drug dosing adjustment in people with reduced GFR

2007

Journal Article

Isolation, propagation and characterization of primary tubule cell culture from human kidney (Methods in Renal Research)

Qi, Weier, Johnson, David W., Vesey, David A., Pollock, Carol A. and Chen, Xinming (2007). Isolation, propagation and characterization of primary tubule cell culture from human kidney (Methods in Renal Research). Nephrology, 12 (2), 155-159. doi: 10.1111/j.1440-1797.2007.00779.x

Isolation, propagation and characterization of primary tubule cell culture from human kidney (Methods in Renal Research)

2007

Journal Article

Silibinin inhibits renal cell carcinoma via mechanisms that are independent if insulin-like growth factor-binding protein 3

Cheung, Catherine W., Vesey, David A., Nicol, David L. and Johnson, David W. (2007). Silibinin inhibits renal cell carcinoma via mechanisms that are independent if insulin-like growth factor-binding protein 3. BJU International, 99 (2), 454-460. doi: 10.1111/j.1464-410X.2007.06571.x

Silibinin inhibits renal cell carcinoma via mechanisms that are independent if insulin-like growth factor-binding protein 3

2007

Journal Article

Potential physiological and pathophysiological roles for protease-activated receptor-2 in the kidney

Vesey, David A., Hooper, John D., Gobe, Glenda C. and Johnson, David W. (2007). Potential physiological and pathophysiological roles for protease-activated receptor-2 in the kidney. Nephrology, 12 (1), 36-43. doi: 10.1111/j.1440-1797.2006.00746.x

Potential physiological and pathophysiological roles for protease-activated receptor-2 in the kidney

2007

Conference Publication

Peritonitis in Australian peritoneal dialysis patients: Microbiology, treatment and outcomes

Ghali, J., McDonald, S., Bannister, K. M., ANZDATA Peritonitis Working Group and Johnson, D. W. (2007). Peritonitis in Australian peritoneal dialysis patients: Microbiology, treatment and outcomes. Nephrology 2007: 43rd Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Gold Coast, QLD, Australia, 8-12 September 2007. Richmond, VIC, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1440-1797.2007.00847.x

Peritonitis in Australian peritoneal dialysis patients: Microbiology, treatment and outcomes

2007

Conference Publication

Molecular and cellular changes associated with age-related chronic kidney disease

Percy, C., Brown, L., Power, D., Johnson, D. W. and Gobe, G. C. (2007). Molecular and cellular changes associated with age-related chronic kidney disease. International Society of Nephrology's World Congress of Nephrology 2007, Rio de Janeiro, Brazil, 21-25 April 2007.

Molecular and cellular changes associated with age-related chronic kidney disease

2007

Conference Publication

Hospital admission rates in alternate nightly nocturnal home haemodialysis

Van Eps, C. L., Jeffries, J. K., Ng, T. G., Isbel, N. M., Johnson, D. W., Campbell, S. B., Mudge, D. W. and Hawley, C. M. (2007). Hospital admission rates in alternate nightly nocturnal home haemodialysis. 43rd Australian and New Zealand Society of Nephrology Annual Scientific Meeting, Gold Coast, Australia, 8–12 September 2007. Hoboken, NJ United States: Wiley-Blackwell.

Hospital admission rates in alternate nightly nocturnal home haemodialysis

2007

Conference Publication

The effect of recombinant human erythropoietin (rhEPO) in renal cell carcinoma (RCC) chemotherapy

Li, J., Vesey, D. A., Johnson, D. W. and Gobe, G. C. (2007). The effect of recombinant human erythropoietin (rhEPO) in renal cell carcinoma (RCC) chemotherapy. World Congress of Nephrology, Rio De Janeiro, Brazil, 21-25 April , 2007. International Society of Nephrology (ISN).

The effect of recombinant human erythropoietin (rhEPO) in renal cell carcinoma (RCC) chemotherapy

2007

Conference Publication

Immunosuppression (IST) Can Be Safely Ceased during Chemotherapy for PTLD in Renal Transplant Patients

Hourigan, Matthew J., Johnson, David W., Jones, Mark, Gill, Devinder S., Isbel, Nikki, Hawley, Carmel M., Marlton, Paula, Ghandhi, Maher, Campbell, Scott B. and Mollee, Peter (2007). Immunosuppression (IST) Can Be Safely Ceased during Chemotherapy for PTLD in Renal Transplant Patients. American Transplant Congress 2007, USA, 5-9 May 2007. UK: Wiley-Blackwell Publising Ltd.. doi: 10.1111/j.1600-6143.2007.01811.x

Immunosuppression (IST) Can Be Safely Ceased during Chemotherapy for PTLD in Renal Transplant Patients

2007

Journal Article

Administration of erythropoietin and its derivatives in renal disease: advantages, mechanisms and concerns

Gobe, Glenda C., Endre, Zoltan H. and Johnson, David W. (2007). Administration of erythropoietin and its derivatives in renal disease: advantages, mechanisms and concerns. Drug Discovery Today: Therapeutic Strategies, 4 (1), 79-84. doi: 10.1016/j.ddstr.2007.07.001

Administration of erythropoietin and its derivatives in renal disease: advantages, mechanisms and concerns

2007

Conference Publication

The effect of diabetes mellitus on access related infection in both peritoneal dialysis and haemodialysis patients

Clark, C. J., Johnson, D., Hawley, C., May, K., Campbell, S., Isbel, N., Mudge, D. and Burke, J. (2007). The effect of diabetes mellitus on access related infection in both peritoneal dialysis and haemodialysis patients. 43rd Australian and New Zealand Society of Nephrology Annual Scientific Meeting, Gold Coast, Australia, 8–12 September 2007. Hoboken, NJ United States: Wiley-Blackwell.

The effect of diabetes mellitus on access related infection in both peritoneal dialysis and haemodialysis patients